Consequences of RAS and MAPK activation in the ovary: The good, the bad and the ugly

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, United States.
Molecular and Cellular Endocrinology (Impact Factor: 4.41). 12/2011; 356(1-2):74-9. DOI: 10.1016/j.mce.2011.12.005
Source: PubMed


This review summarizes studies providing evidence (1) that endogenous RAS activation regulates important physiological events during ovulation and luteinization (2) that expression of the mutant, active KRAS(G12D) in granulosa cells in vivo causes abnormal follicle growth arrest leading to premature ovarian failure and (3) that KRAS(G12D) expression in ovarian surface epithelial (OSE) cells renders them susceptible to the pathological outcome of transformation and tumor formation. These diverse effects of RAS highlight how critical its activation is linked to cell- and stage-specific events in the ovary that control normal processes and that can also lead to altered granulosa cell and OSE cell fates.

Download full-text


Available from: Lisa Mullany
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The controlled target extracellular matrix (ECM) degradation generated by serine protease and regulated by serine protease inhibitor and ovarian paracrine/autocrine factors is an event that affects a wide variety of physiological and pathological processes in the ovary. Evidence cumulated in the past decade clearly showed that the hormone-induced coordinated expression of the tissue-type PA (tPA) produced mainly by granulosa cells and oocyte, and its inhibitor PAI-1 secreted by theca cells in the preovulatory follicles may be responsible for a controlled and directed proteolysis leading to the rupture of selected follicles in the rat, monkey and other mammals. In recent years increasing evidence further demonstrated that oocyte maturation and ovulation may also be modulated by other serine protease and inhibitor, as well as endogenously- produced ovarian paracrine/autocrine factors. Thus, it is important to identify the interrelationship between the serine protease system and the multiple factors, and to know how they regulate the ovarian physiological and pathological processes during oocyte maturation and ovulation.
    Full-text · Article · Jan 2013 · Frontiers in Bioscience
  • [Show abstract] [Hide abstract]
    ABSTRACT: Previous evidence from in vitro studies suggests specific roles for a subset of miRNAs, including miR-21, miR-23a, miR-145, miR-503, miR-224, miR-383, miR-378, miR-132 and miR-212, in regulating ovarian follicle development. The objective of this study was to determine changes in the levels of these miRNAs in relation to follicle selection, maturation and ovulation in the monovular equine ovary. In Experiment 1, follicular fluid was aspirated during ovulatory cycles from the dominant (DO) and largest subordinate (S) follicles of an ovulatory wave, and the dominant (DA) follicle of a mid-cycle anovulatory wave (n=6 mares). Follicular fluid levels of progesterone and estradiol were lower (P<0.01) in S follicles than in DO follicles, whereas mean levels of IGF1 were lower (P<0.01) in S and DA follicles than in DO follicles. Relative to DO and DA follicles, S follicles had higher (P≤0.01) follicular fluid levels of miR-145 and miR-378. In Experiment 2, follicular fluid and granulosa cells were aspirated from dominant follicles before (DO) and 24h after (L) administration of an ovulatory dose of hCG (n=5 mares/group). Relative to DO follicles, L follicles had higher follicular fluid levels of progesterone (P=0.05) and lower granulosa cell levels of CYP19A1 and LHCGR (P<0.005). Levels of miR-21, miR-132, miR-212 and miR-224 were increased (P<0.05) in L follicles; this was associated with reduced expression of the putative miRNA targets, PTEN, RASA1 and SMAD4. These novel results may indicate a physiological involvement of miR-21, miR-145, miR-224, miR-378, miR-132 and miR-212 in the regulation of cell survival, steroidogenesis and differentiation during follicle selection and ovulation in the monovular ovary.
    No preview · Article · Jun 2013 · Reproduction
  • [Show abstract] [Hide abstract]
    ABSTRACT: The luteinizing hormone receptor (LHR) activates several families of heterotrimeric G proteins but only the activation of Gs and subsequent generation of cyclic AMP are universally accepted as important mediators of luteinizing hormone (LH) actions. To examine the involvement of the Gq/11 family on the actions of LH we crossed Cyp19Cre and Gαq(f/f);Gα11(-/-) mice to generate mice with a granulosa cell specific deletion of Gαqin the context of a global deletion of Gα11. Granulosa cells from Gαq(f/f);Gα11(-/-);Cre(+) mice have barely detectable levels of Gαq/11, a normal complement of LHR, and respond to LHR activation with a transient increase in cAMP accumulation, but fail to respond with increased inositol phosphate accumulation, an index of the activation of Gαq/11. The LHR-provoked resumption of meiosis, cumulus expansion and luteinization are normal. However, the Gαq(f/f);Gα11(-/-);Cre(+) mice display severe subfertility because many of the oocytes destined for ovulation become entrapped in preovulatory follicles or corpora lutea. Since follicular rupture is known to be dependent on the expression of the progesterone receptor (Pgr) we examined the LHR-induced expression of Pgr and four of its target genes (Adamts-1, Ctsl1, Edn2 and Prkg2). These actions of the LHR were impaired in the ovaries of the Gαq(f/f);Gα11(-/-);Cre(+) mice. We conclude that the defect in follicular rupture is secondary to failure of the LHR to fully induce the expression of the Pgr. This is the first conclusive evidence for the physiological importance of the activation of Gq/11 by the LHR and for the involvement of Gαq/11 in ovulation.
    No preview · Article · Jul 2013 · Molecular Endocrinology
Show more